Syngene International Limited
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and anal… Read more
Market Cap & Net Worth: Syngene International Limited (SYNGENE)
Syngene International Limited (NSE:SYNGENE) has a market capitalization of $1.91 Billion (₹165.13 Billion) as of March 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #8055 globally and #313 in its home market, demonstrating a 2.84% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Syngene International Limited's stock price ₹411.05 by its total outstanding shares 401715908 (401.72 Million).
Syngene International Limited Market Cap History: 2015 to 2026
Syngene International Limited's market capitalization history from 2015 to 2026. Data shows growth from $955.07 Million to $1.95 Billion (7.97% CAGR).
Index Memberships
Syngene International Limited is a constituent of 5 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY 500
NIFTY500
|
$1.27 Trillion | 0.07% | #280 of 500 |
|
NIFTY HEALTHCARE
NIFTYHEALTHCARE
|
$71.96 Billion | 1.16% | #17 of 20 |
|
NIFTY MIDCAP 150
NIFTYMIDCAP150
|
$342.58 Billion | 0.24% | #124 of 150 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$535.73 Billion | 0.16% | #193 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$1.32 Trillion | 0.06% | #283 of 750 |
Weight: Syngene International Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Syngene International Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Syngene International Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.08x
Syngene International Limited's market cap is 0.08 times its annual revenue
0.69x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.61x
Syngene International Limited's market cap is 0.61 times its annual earnings
363.13x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.29 Billion | $11.07 Billion | $2.41 Billion | 0.12x | 0.54x |
| 2017 | $1.25 Billion | $12.01 Billion | $2.87 Billion | 0.10x | 0.43x |
| 2018 | $1.29 Billion | $14.23 Billion | $3.05 Billion | 0.09x | 0.42x |
| 2019 | $1.48 Billion | $18.26 Billion | $3.32 Billion | 0.08x | 0.45x |
| 2020 | $2.96 Billion | $20.12 Billion | $4.12 Billion | 0.15x | 0.72x |
| 2021 | $2.87 Billion | $21.84 Billion | $4.05 Billion | 0.13x | 0.71x |
| 2022 | $2.71 Billion | $26.04 Billion | $3.96 Billion | 0.10x | 0.68x |
| 2023 | $3.25 Billion | $31.93 Billion | $4.64 Billion | 0.10x | 0.70x |
| 2024 | $3.98 Billion | $34.89 Billion | $5.10 Billion | 0.11x | 0.78x |
| 2025 | $3.02 Billion | $36.42 Billion | $4.96 Billion | 0.08x | 0.61x |
Competitor Companies of SYNGENE by Market Capitalization
Companies near Syngene International Limited in the global market cap rankings as of March 19, 2026.
Key companies related to Syngene International Limited by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Syngene International Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Syngene International Limited's market cap moved from $955.07 Million to $ 1.95 Billion, with a yearly change of 7.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹1.95 Billion | -35.51% |
| 2025 | ₹3.02 Billion | -24.17% |
| 2024 | ₹3.98 Billion | +22.60% |
| 2023 | ₹3.25 Billion | +19.91% |
| 2022 | ₹2.71 Billion | -5.46% |
| 2021 | ₹2.87 Billion | -3.08% |
| 2020 | ₹2.96 Billion | +99.78% |
| 2019 | ₹1.48 Billion | +14.48% |
| 2018 | ₹1.29 Billion | +3.66% |
| 2017 | ₹1.25 Billion | -3.45% |
| 2016 | ₹1.29 Billion | +35.23% |
| 2015 | ₹955.07 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Syngene International Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.91 Billion USD |
| MoneyControl | $1.91 Billion USD |
| MarketWatch | $1.91 Billion USD |
| marketcap.company | $1.91 Billion USD |
| Reuters | $1.91 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.